Browse Internal Medicine Articles by Topic

Do Multivitamin-mineral Supplements Protect Against CVD Mortality?

An association was found between decreased death from cardiovascular disease and U.S. women’s use of multivitamin-mineral supplements when taken for at least 3 years. A similar association was not found for men, nor for either gender after use of multivitamins without minerals.

Energy Medicine: Is There Evidence?

Despite insufficient evidence to support clinical guidelines, the safety and accessibility of energy therapies make them viable options as adjunct treatments.

Alternating Morphology Every-other-beat

Interpretation: The underlying rhythm in this simultaneously recorded 3-lead tracing is a narrow-complex tachycardia.

The Quandry Over Preventing Delerium in Acute Respiratory Distress Syndrome

A significantly higher incidence of delirium was found in patients with acute respiratory distress syndrome (ARDS).

Communicating About Prognosis in the ICU

Effectively communicating a prognosis to a patient’s surrogates in the ICU can be challenging.

Post Intensive Care Syndrome: Risk Factors and Prevention Strategies

Each year, approximately 800,000 patients in the United States develop an illness that results in admission to an ICU and need for mechanical ventilation.

Peramivir: A Newly Approved Antiviral for Treatment of Influenza

Peramivir (Rapivab™) was recently approved by the FDA in December 2014 for treatment of acute uncomplicated influenza within two days of symptom onset. This newly approved antiviral is a neuraminidase inhibitor (NI) similar to oseltamivir and zanamivir but the first to be approved in an injectable formulation.1 Peramivir has been licensed in Japan (as Rapiacta) and South Korea (as PeramiFlu) since 2010. In addition, it has been used in the United States on an emergency basis during the 2009 H1N1 flu pandemic.

Report from the International Stroke Conference 2015

Major announcements at the International Stroke Conference 2015 in Nashville, Tennessee, included reports on three trials that compared endovascular clot retrieval for acute ischemic stroke, compared to medical treatment with intravenous thrombolytics alone.

Intracranial Hemorrhage Risk: Are Novel Oral Anticoagulants Better Than Warfarin?

Clinicians have commonly overestimated the risk of intracerebral hemorrhage (ICH) during anticoagulant therapy. Indeed, such misapprehensions have sometimes led to failure to employ warfarin (and probably other agents) when indicated for atrial fibrillation.

Multicenter Quality Improvement Project Resulted in a 23% Reduction in Medical Errors

SYNOPSIS: Implementation of a quality improvement project focused on handoffs reduced medical errors by 23% and preventable adverse events by 30%.